A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

NCT07475806 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscle-invasive Bladder Cancer

Interventions

DRUG: Enfortumab Vedotin
DRUG: Pembrolizumab

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators

[object Object]